Morgan Stanley’s Portfolio Building Block World Pharma and Biotech Index ETF PBPH Stock Holding History

Morgan Stanley’s Portfolio PBPH Stock Details PBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.39K	Buy	+272	New	+$6.93K	﹤0.01%	7128

Other funds holding PBPH

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

CX Institutional Auburn, Indiana $3.46B AUM 21.89% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return

Morgan Stanley's PBPH Position: Q2 2026 in Review

Morgan Stanley opened a new position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) in Q2 2026: 272 shares worth $7.39K. The stake represents ﹤0.01% of the portfolio and ranks #7128 among its holdings.

10 funds tracked by Wall St. Rank hold PBPH as of Q2 2026.

Morgan Stanley held 272 shares of Portfolio Building Block World Pharma and Biotech Index ETF worth $7.39K as of Q2 2026.
Portfolio Building Block World Pharma and Biotech Index ETF was a new Morgan Stanley position in Q2 2026.
Portfolio Building Block World Pharma and Biotech Index ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7128 holding.
10 funds tracked by Wall St. Rank held Portfolio Building Block World Pharma and Biotech Index ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.